Alternative polyadenylation signals and promoters act in concert to control tissue-specific expression of the Opitz Syndrome gene MID1
2007

How MID1 Gene Expression is Controlled in Different Tissues

publication Evidence: moderate

Author Information

Author(s): Jennifer Winter, Melanie Kunath, Stefan Roepcke, Sven Krause, Rainer Schneider, Susann Schweiger

Primary Institution: Max-Planck Institute for Molecular Genetics, Berlin-Dahlem, Germany

Hypothesis

The study hypothesizes that alternative polyadenylation generates size differences in MID1 transcripts and that these differences are regulated by alternative promoters.

Conclusion

The expression of the MID1 gene is tightly regulated through the combined action of alternative promoters and polyadenylation signals during development and in adults.

Supporting Evidence

  • The MID1 gene has multiple alternative promoters and polyadenylation sites.
  • Different MID1 transcripts are expressed in a tissue-specific manner.
  • The study identified several conserved RNA-protein interaction motifs in the MID1 3'UTR.

Takeaway

The MID1 gene can make different versions of itself depending on the tissue, which helps control how it works in the body.

Methodology

The study used Northern blot analyses, RT-PCR, and bioinformatic tools to analyze MID1 gene expression and alternative polyadenylation.

Limitations

The study does not provide definitive statements about the relative expression levels of the different MID1 transcripts due to overlapping sequences.

Digital Object Identifier (DOI)

10.1186/1471-2199-8-105

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication